The emerging function of N6-methyladenosine and its regulators in endometrial cancer; Current knowledge and prospect

Saved in:
Bibliographic Details
Published inHuman gene (Amsterdam, Netherlands) Vol. 38; p. 201232
Main Authors Rabiei, Maryam, Ghalandarpoor-Attar, Seyedeh Mojgan, Ghalandarpoor-Attar, Seyedeh Noushin, Nurzadeh, Maryam
Format Journal Article
LanguageEnglish
Published 01.12.2023
Online AccessGet full text

Cover

ArticleNumber 201232
Author Ghalandarpoor-Attar, Seyedeh Mojgan
Ghalandarpoor-Attar, Seyedeh Noushin
Rabiei, Maryam
Nurzadeh, Maryam
Author_xml – sequence: 1
  givenname: Maryam
  surname: Rabiei
  fullname: Rabiei, Maryam
– sequence: 2
  givenname: Seyedeh Mojgan
  surname: Ghalandarpoor-Attar
  fullname: Ghalandarpoor-Attar, Seyedeh Mojgan
– sequence: 3
  givenname: Seyedeh Noushin
  surname: Ghalandarpoor-Attar
  fullname: Ghalandarpoor-Attar, Seyedeh Noushin
– sequence: 4
  givenname: Maryam
  surname: Nurzadeh
  fullname: Nurzadeh, Maryam
BookMark eNpNkMtOwzAURC1UJErpH7DwD6T4kbiJWKGKl1TBpqwt27lOXRK7sh2h_j2twoLNzCxm7pXOLZr54AGhe0pWlFDxcFjtx6EDv2KE8bNQxtkVmrP1mhekLOnsX75By5QOhBDOaFMxOkd5twcMA8TO-Q7b0ZvsgsfB4g9RDJD3p1614ENyHrDyLXY54Qjd2KscYsLOY_BtODejUz02yhuIj3gzxgg-428ffnpou2l7jCEdweQ7dG1Vn2D55wv09fK827wV28_X983TtjCsqnIBjBjCBNFa1I0WmjZE6KpRdVmzUle2otQKbbluTFuCZcJqxWpG15VVta4bvkDldNecH6cIVh6jG1Q8SUrkBZ48yAmevMCTEzz-C4ezaJ4
Cites_doi 10.7150/jca.54527
10.1016/j.omtn.2019.11.022
10.18632/aging.203157
10.1002/mc.22782
10.1016/j.advms.2019.08.003
10.1371/journal.pone.0159072
10.1038/nature13138
10.1016/j.semcancer.2020.11.007
10.1158/1541-7786.MCR-20-0541
10.1186/s12943-019-1004-4
10.3892/or.2016.4613
10.1016/j.ccell.2020.04.017
10.1002/cbin.11570
10.1016/j.heliyon.2022.e09178
10.1186/s12935-019-1045-1
10.1136/gutjnl-2014-308614
10.1021/cn500042t
10.1097/MD.0000000000026551
10.7150/thno.49345
10.7150/jca.46097
10.1038/s41422-018-0040-8
10.1097/01.NAJ.0000577332.56265.51
10.1186/s12943-018-0930-x
10.1038/s41556-018-0174-4
10.1126/sciadv.aar8263
10.20892/j.issn.2095-3941.2018.0365
10.1016/j.biopha.2019.108613
10.1016/j.ygyno.2016.12.010
10.1097/MD.0000000000026648
10.3322/caac.21654
10.1038/nrm.2016.132
10.1016/j.cell.2017.11.031
10.18632/oncotarget.22041
10.1016/S0140-6736(22)00323-3
10.1186/s13000-021-01088-1
10.2147/IJGM.S336403
10.1080/08820139.2018.1480029
10.1158/0008-5472.CAN-18-2965
10.7150/jca.50868
10.1186/s12885-022-10490-x
10.1016/j.canlet.2011.12.033
10.1007/s11033-019-05078-x
10.1615/CritRevEukaryotGeneExpr.2020035372
10.1186/s13046-019-1159-2
10.1186/s13048-020-00729-1
10.1038/nrg1879
10.1038/s41422-018-0034-6
10.1038/s41374-021-00543-3
10.1080/15476286.2020.1841458
10.1080/13543784.2018.1558202
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1016/j.humgen.2023.201232
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
EISSN 2773-0441
ExternalDocumentID 10_1016_j_humgen_2023_201232
GroupedDBID 0R~
AALRI
AATTM
AAXKI
AAXUO
AAYWO
AAYXX
ABJNI
ACRLP
ACVFH
ADCNI
AEHWI
AEIPS
AEUPX
AFJKZ
AFPUW
AFXIZ
AGRNS
AIGII
AIIUN
AIKHN
AITUG
AKBMS
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
APXCP
BNPGV
CITATION
EBS
EFJIC
FDB
FYGXN
M41
ROL
SSH
SSU
ID FETCH-LOGICAL-c255t-e20c0260bb689b6b1906b59a84824b5f511f6bf3b9cd4ef26fba282175fa8b893
ISSN 2773-0441
IngestDate Tue Jul 01 02:46:36 EDT 2025
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c255t-e20c0260bb689b6b1906b59a84824b5f511f6bf3b9cd4ef26fba282175fa8b893
ParticipantIDs crossref_primary_10_1016_j_humgen_2023_201232
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-00
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-00
PublicationDecade 2020
PublicationTitle Human gene (Amsterdam, Netherlands)
PublicationYear 2023
References Zou (10.1016/j.humgen.2023.201232_bb0270) 2019; 19
Singh (10.1016/j.humgen.2023.201232_bb0145) 2016; 11
Wang (10.1016/j.humgen.2023.201232_bb0185) 2017; 8
Shi (10.1016/j.humgen.2023.201232_bb0135) 2021; 14
Song (10.1016/j.humgen.2023.201232_bb0155) 2022; 37
Li (10.1016/j.humgen.2023.201232_bb0075) 2021; 45
Hong (10.1016/j.humgen.2023.201232_bb0055) 2021; 12
Barra (10.1016/j.humgen.2023.201232_bb0010) 2019; 28
Pu (10.1016/j.humgen.2023.201232_bb0110) 2020; 11
Su (10.1016/j.humgen.2023.201232_bb0165) 2020; 38
Zheng (10.1016/j.humgen.2023.201232_bb0250) 2014; 5
Zhao (10.1016/j.humgen.2023.201232_bb0245) 2020; 19
Deng (10.1016/j.humgen.2023.201232_bb0025) 2018; 28
Fang (10.1016/j.humgen.2023.201232_bb0035) 2022; 22
Katz (10.1016/j.humgen.2023.201232_bb0060) 2019; 119
Lewczuk (10.1016/j.humgen.2023.201232_bb0070) 2019; 64
Liu (10.1016/j.humgen.2023.201232_bb0080) 2018; 20
Suarez (10.1016/j.humgen.2023.201232_bb0170) 2017; 144
Xiao (10.1016/j.humgen.2023.201232_bb0190) 2021; 19
Niu (10.1016/j.humgen.2023.201232_bb0090) 2019; 18
Panneerdoss (10.1016/j.humgen.2023.201232_bb0100) 2018; 4
Shen (10.1016/j.humgen.2023.201232_bb0130) 2021; 101
Zhang (10.1016/j.humgen.2023.201232_bb0225) 2021; 100
Zhao (10.1016/j.humgen.2023.201232_bb0240) 2017; 18
Ma (10.1016/j.humgen.2023.201232_bb0085) 2021; 13
Pinello (10.1016/j.humgen.2023.201232_bb0105) 2018; 15
Siegel (10.1016/j.humgen.2023.201232_bb0140) 2021; 71
Ashjari (10.1016/j.humgen.2023.201232_bb0005) 2022; 8
Zafari (10.1016/j.humgen.2023.201232_bb0205) 2018; 47
Han (10.1016/j.humgen.2023.201232_bb0045) 2020; 10
Sun (10.1016/j.humgen.2023.201232_bb0175) 2019; 112
Zhang (10.1016/j.humgen.2023.201232_bb0235) 2021; 18
Pang (10.1016/j.humgen.2023.201232_bb0095) 2021; 100
Yang (10.1016/j.humgen.2023.201232_bb0200) 2018; 28
Zhou (10.1016/j.humgen.2023.201232_bb0255) 2018; 57
Ralser (10.1016/j.humgen.2023.201232_bb0115) 2022
Zhang (10.1016/j.humgen.2023.201232_bb0220) 2016; 65
Vafaei (10.1016/j.humgen.2023.201232_bb0180) 2020; 30
Samimi (10.1016/j.humgen.2023.201232_bb0120) 2019; 46
Lan (10.1016/j.humgen.2023.201232_bb0065) 2019; 79
Engelman (10.1016/j.humgen.2023.201232_bb0030) 2006; 7
Su (10.1016/j.humgen.2023.201232_bb0160) 2018; 172
Crosbie (10.1016/j.humgen.2023.201232_bb0020) 2022; 399
Sharbatoghli (10.1016/j.humgen.2023.201232_bb0125) 2020; 13
Han (10.1016/j.humgen.2023.201232_bb0050) 2021; 75
Zhang (10.1016/j.humgen.2023.201232_bb0230) 2021; 11
Zhu (10.1016/j.humgen.2023.201232_bb0260) 2016; 35
Fattahi (10.1016/j.humgen.2023.201232_bb0040) 2021; 16
Zhang (10.1016/j.humgen.2023.201232_bb0215) 2012; 319
Smemo (10.1016/j.humgen.2023.201232_bb0150) 2014; 507
Zhu (10.1016/j.humgen.2023.201232_bb0265) 2019; 38
Chen (10.1016/j.humgen.2023.201232_bb0015) 2019; 18
Xue (10.1016/j.humgen.2023.201232_bb0195) 2021; 6
Zhai (10.1016/j.humgen.2023.201232_bb0210) 2021; 12
References_xml – volume: 12
  start-page: 3809
  issue: 13
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0055
  article-title: YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A
  publication-title: J. Cancer
  doi: 10.7150/jca.54527
– volume: 19
  start-page: 405
  year: 2020
  ident: 10.1016/j.humgen.2023.201232_bb0245
  article-title: Epigenetic regulation of m6A modifications in human cancer
  publication-title: Mol. Ther.–Nucleic Acids
  doi: 10.1016/j.omtn.2019.11.022
– volume: 13
  start-page: 16287
  issue: 12
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0085
  article-title: Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.203157
– volume: 10
  start-page: 727
  issue: 3
  year: 2020
  ident: 10.1016/j.humgen.2023.201232_bb0045
  article-title: PD-1/PD-L1 pathway: current researches in cancer
  publication-title: Am. J. Cancer Res.
– volume: 57
  start-page: 590
  issue: 5
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0255
  article-title: FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.22782
– volume: 64
  start-page: 423
  issue: 2
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0070
  article-title: Cell adhesion molecules in endometrial cancer–a systematic review
  publication-title: Adv. Med. Sci.
  doi: 10.1016/j.advms.2019.08.003
– volume: 11
  issue: 7
  year: 2016
  ident: 10.1016/j.humgen.2023.201232_bb0145
  article-title: Important role of FTO in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0159072
– volume: 507
  start-page: 371
  issue: 7492
  year: 2014
  ident: 10.1016/j.humgen.2023.201232_bb0150
  article-title: Obesity-associated variants within FTO form long-range functional connections with IRX3
  publication-title: Nature
  doi: 10.1038/nature13138
– volume: 75
  start-page: 97
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0050
  article-title: RNA methylations in human cancers
  publication-title: Semin. Cancer
  doi: 10.1016/j.semcancer.2020.11.007
– start-page: 1
  year: 2022
  ident: 10.1016/j.humgen.2023.201232_bb0115
  article-title: Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
  publication-title: J. Cancer Res. Clin. Oncol.
– volume: 19
  start-page: 726
  issue: 4
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0190
  article-title: Exosomal delivery of FTO confers Gefitinib resistance to recipient cells through ABCC10 regulation in an m6A-dependent MannerExo-FTO transmits Gefitinib resistance in NSCLC
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-20-0541
– volume: 18
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0090
  article-title: RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-019-1004-4
– volume: 35
  start-page: 2391
  issue: 4
  year: 2016
  ident: 10.1016/j.humgen.2023.201232_bb0260
  article-title: Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2016.4613
– volume: 38
  start-page: 79
  issue: 1
  year: 2020
  ident: 10.1016/j.humgen.2023.201232_bb0165
  article-title: Targeting FTO suppresses cancer stem cell maintenance and immune evasion
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.04.017
– volume: 45
  start-page: 1269
  issue: 6
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0075
  article-title: WTAP facilitates progression of endometrial cancer via CAV-1/NF-κB axis
  publication-title: Cell Biol. Int.
  doi: 10.1002/cbin.11570
– volume: 8
  issue: 3
  year: 2022
  ident: 10.1016/j.humgen.2023.201232_bb0005
  article-title: The axis of long non-coding RNA MALAT1/miR-1-3p/CXCR4 is dysregulated in patients with diabetic neuropathy
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2022.e09178
– volume: 19
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0270
  article-title: The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-019-1045-1
– volume: 65
  start-page: 1482
  issue: 9
  year: 2016
  ident: 10.1016/j.humgen.2023.201232_bb0220
  article-title: Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP–WT1–TBL1 axis
  publication-title: Gut
  doi: 10.1136/gutjnl-2014-308614
– volume: 5
  start-page: 658
  issue: 8
  year: 2014
  ident: 10.1016/j.humgen.2023.201232_bb0250
  article-title: Synthesis of a FTO inhibitor with anticonvulsant activity
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/cn500042t
– volume: 100
  issue: 26
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0095
  article-title: Development and validation of m6A regulators’ prognostic significance for endometrial cancer
  publication-title: Medicine
  doi: 10.1097/MD.0000000000026551
– volume: 11
  start-page: 1100
  issue: 3
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0230
  article-title: IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression
  publication-title: Theranostics
  doi: 10.7150/thno.49345
– volume: 11
  start-page: 5612
  issue: 19
  year: 2020
  ident: 10.1016/j.humgen.2023.201232_bb0110
  article-title: ALKBH5 regulates IGF1R expression to promote the proliferation and tumorigenicity of endometrial cancer
  publication-title: J. Cancer
  doi: 10.7150/jca.46097
– volume: 28
  start-page: 616
  issue: 6
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0200
  article-title: Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
  publication-title: Cell Res.
  doi: 10.1038/s41422-018-0040-8
– volume: 119
  start-page: 34
  issue: 8
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0060
  article-title: CE: obesity-related cancer in women: a clinical review
  publication-title: AJN Am. J. Nurs.
  doi: 10.1097/01.NAJ.0000577332.56265.51
– volume: 18
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0015
  article-title: The role of m6A RNA methylation in human cancer
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-018-0930-x
– volume: 20
  start-page: 1074
  issue: 9
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0080
  article-title: m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-018-0174-4
– volume: 4
  issue: 10
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0100
  article-title: Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aar8263
– volume: 15
  start-page: 323
  issue: 4
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0105
  article-title: Aberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer
  publication-title: Cancer Biol. Med.
  doi: 10.20892/j.issn.2095-3941.2018.0365
– volume: 112
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0175
  article-title: The role of m6A RNA methylation in cancer
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2019.108613
– volume: 37
  start-page: 737
  issue: 9
  year: 2022
  ident: 10.1016/j.humgen.2023.201232_bb0155
  article-title: The role of N6-methyladenosine methylation in the progression of endometrial cancer
  publication-title: Cancer Biother. Radiopharm.
– volume: 144
  start-page: 243
  issue: 2
  year: 2017
  ident: 10.1016/j.humgen.2023.201232_bb0170
  article-title: Bokhman redux: endometrial cancer “types” in the 21st century
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2016.12.010
– volume: 100
  issue: 29
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0225
  article-title: A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma
  publication-title: Medicine
  doi: 10.1097/MD.0000000000026648
– volume: 6
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0195
  article-title: Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
  publication-title: Signal Transduct. Target. Ther.
– volume: 71
  start-page: 7
  issue: 1
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0140
  article-title: Cancer statistics, 2021
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21654
– volume: 18
  start-page: 31
  issue: 1
  year: 2017
  ident: 10.1016/j.humgen.2023.201232_bb0240
  article-title: Post-transcriptional gene regulation by mRNA modifications
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm.2016.132
– volume: 172
  start-page: 90
  issue: 1–2
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0160
  article-title: R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling
  publication-title: Cell
  doi: 10.1016/j.cell.2017.11.031
– volume: 8
  start-page: 98918
  issue: 58
  year: 2017
  ident: 10.1016/j.humgen.2023.201232_bb0185
  article-title: Reduced m6A mRNA methylation is correlated with the progression of human cervical cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.22041
– volume: 399
  start-page: 1412
  issue: 10333
  year: 2022
  ident: 10.1016/j.humgen.2023.201232_bb0020
  article-title: Endometrial cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)00323-3
– volume: 16
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0040
  article-title: Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
  publication-title: Diagn. Pathol.
  doi: 10.1186/s13000-021-01088-1
– volume: 14
  start-page: 8249
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0135
  article-title: N6-Methyladenosine-related long noncoding RNAs as potential prognosis biomarkers for endometrial Cancer
  publication-title: Int. J. Gen. Med.
  doi: 10.2147/IJGM.S336403
– volume: 47
  start-page: 632
  issue: 6
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0205
  article-title: Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed rheumatoid arthritis patients
  publication-title: Immunol. Investig.
  doi: 10.1080/08820139.2018.1480029
– volume: 79
  start-page: 1285
  issue: 7
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0065
  article-title: The critical role of RNA m6A methylation in cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-2965
– volume: 12
  start-page: 4729
  issue: 15
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0210
  article-title: Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma
  publication-title: J. Cancer
  doi: 10.7150/jca.50868
– volume: 22
  start-page: 1364
  issue: 1
  year: 2022
  ident: 10.1016/j.humgen.2023.201232_bb0035
  article-title: m6A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinoma
  publication-title: BMC Cancer
  doi: 10.1186/s12885-022-10490-x
– volume: 319
  start-page: 89
  issue: 1
  year: 2012
  ident: 10.1016/j.humgen.2023.201232_bb0215
  article-title: Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2011.12.033
– volume: 46
  start-page: 6353
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0120
  article-title: The impaired gene expression of adenosine monophosphate-activated kinase (AMPK), a key metabolic enzyme in leukocytes of newly diagnosed rheumatoid arthritis patients
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-019-05078-x
– volume: 30
  issue: 5
  year: 2020
  ident: 10.1016/j.humgen.2023.201232_bb0180
  article-title: Dynamic signature of tRNA-derived small RNAs in cancer pathogenesis as a promising valuable approach
  publication-title: Crit. Rev. Eukaryot. Gene Expr.
  doi: 10.1615/CritRevEukaryotGeneExpr.2020035372
– volume: 38
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0265
  article-title: ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-019-1159-2
– volume: 13
  start-page: 1
  year: 2020
  ident: 10.1016/j.humgen.2023.201232_bb0125
  article-title: Prediction of the treatment response in ovarian cancer: a ctDNA approach
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-020-00729-1
– volume: 7
  start-page: 606
  issue: 8
  year: 2006
  ident: 10.1016/j.humgen.2023.201232_bb0030
  article-title: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1879
– volume: 28
  start-page: 507
  issue: 5
  year: 2018
  ident: 10.1016/j.humgen.2023.201232_bb0025
  article-title: RNA N6-methyladenosine modification in cancers: current status and perspectives
  publication-title: Cell Res.
  doi: 10.1038/s41422-018-0034-6
– volume: 101
  start-page: 775
  issue: 6
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0130
  article-title: N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma
  publication-title: Lab. Investig.
  doi: 10.1038/s41374-021-00543-3
– volume: 18
  start-page: 1265
  issue: 9
  year: 2021
  ident: 10.1016/j.humgen.2023.201232_bb0235
  article-title: FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway
  publication-title: RNA Biol.
  doi: 10.1080/15476286.2020.1841458
– volume: 28
  start-page: 131
  issue: 2
  year: 2019
  ident: 10.1016/j.humgen.2023.201232_bb0010
  article-title: Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
  publication-title: Expert Opin. Investig. Drugs
  doi: 10.1080/13543784.2018.1558202
SSID ssj0003219521
Score 2.2400398
SecondaryResourceType review_article
SourceID crossref
SourceType Index Database
StartPage 201232
Title The emerging function of N6-methyladenosine and its regulators in endometrial cancer; Current knowledge and prospect
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbKduGChgbix0A-cHXUJrHraqdqAk0IKjQ2abfITmzaiiaoSg7dH7q_h_fsOAlbBRuXqIocx_L7an9-ee97hHwYx0YIMCxm42iWTiYW_lKSs1jJaaHkzCiF-c5fF-L8Kv18za9Ho9tB1FJT6yi_2ZtX8j9WhXtgV8ySfYRlu07hBvwG-8IVLAzXB9sYE3xdoSHcoQL9WwiGpaF3P1WBYuDIJPuPBK74PNbYQbWQsqg2xpfuyBEAW9T0D6JNncOtlROoXF7mkM_6bwAwQEdV5xuUXShajPWpxAN3w4XSK7Nqs4R2atPF_yxdjKXCml9bNq9rH_j93exMYZaw9Kx_9Dj-R-NF1aBjrfNzN9sbmIflnZe2ro44GYSNuBUxnk4TNk69UlZk9txrl3QvGBPWZEcb924X3nOxjpbNBmYqwndGffM_1bnv7JpdLGMIk1tnvpcMe8l8L0_IIYwPifvh_Oziy7fO-5fARsFdUmA3_pDX6YIP7w9owJsGBOjyiDxrTy507mH4nIxMeUxqgCANEKQBgrSy9D4EKZiMAgRpD0G6KukAgtRD8JS2AKQdAN2zAYAvyNWnj5dn56wt5MFyOLHWzMTjHLXrtBZypoUGEio0nymZyjjV3ALpt0LbRM_yIjU2FlarWMJhmVslNTDql-SgrErzitBEGcWt0UJNk1QnXHEZq2KiOC_gsG_S14SFacp-eb2W7G8WevPI9m_J0x6ZJ-Sg3jbmHdDSWr9vbfwbGBKTPA
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+emerging+function+of+N6-methyladenosine+and+its+regulators+in+endometrial+cancer%3B+Current+knowledge+and+prospect&rft.jtitle=Human+gene+%28Amsterdam%2C+Netherlands%29&rft.au=Rabiei%2C+Maryam&rft.au=Ghalandarpoor-Attar%2C+Seyedeh+Mojgan&rft.au=Ghalandarpoor-Attar%2C+Seyedeh+Noushin&rft.au=Nurzadeh%2C+Maryam&rft.date=2023-12-01&rft.issn=2773-0441&rft.eissn=2773-0441&rft.volume=38&rft.spage=201232&rft_id=info:doi/10.1016%2Fj.humgen.2023.201232&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_humgen_2023_201232
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2773-0441&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2773-0441&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2773-0441&client=summon